December 2, 2021 11:40 AM EST
Manufacturing

Fu­ji­film Diosynth dumps an­oth­er $454M in­to its sup­ply chain, this time at a fa­cil­i­ty in the UK

Josh Sullivan

Fu­ji­film Diosynth Biotech­nolo­gies is in the mid­dle of a mon­u­men­tal point in the com­pa­ny’s 10-year his­to­ry, and the CD­MO is about to grow even more …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Ver­sant un­veils Light Horse with $62M and a part­ner­ship with No­var­tis

Af­ter lack­lus­ter 2024, bio­phar­ma in­dus­try prays stalled M&A will fi­nal­ly move in­to gear

Aio­los team re­unites with $411M for new biotech with obe­si­ty drugs from Chi­na

Ex­clu­sive: First-of-its-kind in­fant DNA ed­it leads to ap­par­ent cure in dis­ease that set back field 25 years ago

Cell ther­a­py start­up A2 Bio­ther­a­peu­tics nets $80M Se­ries C

Ley­den Labs gets $70M to test if nasal sprays can help pro­tect against virus­es

A service from the Financial Times